![Ravi Rao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ravi Rao
Direktör/Styrelseledamot på
DBV TECHNOLOGIES
Förmögenhet: - $ per 2026-05-31
Profil
Currently, Ravi Madduri Rao is an Independent Director at DBV Technologies SA since 2021, a Non-Executive Director at Autolus Therapeutics Plc since 2024, a Venture Partner at SV Health Investors LLP since 2022, a Member of The Royal College of Physicians, and Chief Medical Officer at Sitryx Therapeutics Ltd. since 2022.
Formerly, the roles include Chief Medical Officer at Spyre Therapeutics, Inc. from 2019 to 2020, Head-Global Medical Affairs at GSK Plc from 2016 to 2019, Chief Medical Officer and Head-Research & Development at Swedish Orphan Biovitrum AB from 2020 to 2022, and Chief Medical Officer at Oxford Biomedica Plc from 2022 to 2023.
Education includes a doctorate from Imperial College London and an undergraduate degree from the University of Cambridge.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-18 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Ravi Rao
| Företag | Position | Start |
|---|---|---|
| DBV TECHNOLOGIES | Direktör/Styrelseledamot | 2021-05-19 |
| AUTOLUS THERAPEUTICS PLC | Direktör/Styrelseledamot | 2024-04-01 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Teknisk/Vetenskaplig/F&U Direktör | 2022-04-01 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Privat kapitalinvesterare | 2022-03-01 |
Tidigare kända positioner av Ravi Rao
| Företag | Position | Slut |
|---|---|---|
| OXFORD BIOMEDICA PLC | Företagsledare/Principal | 2023-11-01 |
| SWEDISH ORPHAN BIOVITRUM AB | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-01 |
| SPYRE THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-08-10 |
| GSK PLC | Teknisk/Vetenskaplig/F&U Direktör | 2019-10-01 |
Ravi Raos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
83
Första gradens relationer
11
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Health Technology |
